|
Corporate News
10-Nov-23
|
|
|
|
|
|
|
Biocon Biologics divests its non-crore branded formulations biz in India
|
|
|
|
Biocon Biologics, a subsidiary of Biocon has divested the businesses in relation to its non-core branded formulations in India, comprising, inter alia, of generic dermatology and nephrology small molecule formulations (BFI Non-Core Business) to Eris Lifesciences on a ‘slump sale' basis.
|
|
Previous News |
Stock alert: Sapphire Foods, ICICI Bank, Adani Power, Rail Vikas Nigam
(
Market Commentary
-
Stock Alert
04-Jun-24
08:42
)
|
|
Biocon signs distribution and supply agreement with Medix
(
Corporate News
-
13-May-24
09:36
)
|
|
Stock Alert: Indegene, Wipro, Biocon, HUDCO
(
Market Commentary
-
Stock Alert
13-May-24
08:28
)
|
|
Biocon Ltd rises for third consecutive session
(
Hot Pursuit
-
20-Aug-24
13:05
)
|
|
Biocon Ltd soars 3.74%, rises for third straight session
(
Hot Pursuit
-
02-Jan-24
13:05
)
|
|
Biocon inks pact with Medix to commercialize weight mgmt product
(
Hot Pursuit
-
13-May-24
08:05
)
|
|
Biocon to declare Quarterly Result
(
Corporate News
-
11-Jan-24
11:42
)
|
|
Biocon Ltd spurts 0.78%, up for five straight sessions
(
Hot Pursuit
-
08-Nov-23
13:01
)
|
|
Biocon Ltd soars 1.18%, Gains for third straight session
(
Hot Pursuit
-
26-Dec-23
13:05
)
|
|
Board of Biocon to consider NCD issuance and investment in Biocon Biologics
(
Corporate News
-
24-Apr-23
09:50
)
|
|
Biocon arm completes integration of Viatris biosimilars biz
(
Hot Pursuit
-
07-Sep-23
09:45
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|